A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of
Authors:
Journal: Journal of the American College of Cardiology
Publication Type: Clinical Trial
Date: 2005
DOI: 10.1016/j.jacc.2005.02.061
ID: 15936605
Abstract
The purpose of this research was to determine the effect of intravenous adenosine on clinical outcomes and infarct size in ST-segment elevation myocardial infarction (STEMI) patients undergoing reperfusion therapy.
Chemical List
- Vasodilator Agents|||Adenosine